- Filed
- Apr 17, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Apr 17, 2025 | 3.18M sh |
| Cash And Equivalents | Q3 2025 · Mar 31, 2025 | $3.8K |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $29.35K |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $78.71K |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $78.5K |
| Current Assets | Q3 2025 · Mar 31, 2025 | $3.8K |
| Current Assets | Q3 2025 · Jun 30, 2024 | $29.35K |
| Total Assets | Q3 2025 · Mar 31, 2025 | $51.23K |
| Total Assets | Q3 2025 · Jun 30, 2024 | $78.85K |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 3.16M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 2.78M sh |
| Operating Cash Flow restated | Q3 2025 · Mar 31, 2024 | −$15.15K |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $5.43K |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $9.71K |
| Stockholders Equity | Q3 2025 · Sep 30, 2023 | −$3.58K |
| Stockholders Equity | Q3 2025 · Jun 30, 2023 | −$19.09K |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | $0.00 |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $5.19K |
| Sga Expense restated | Q3 2025 · Mar 31, 2024 | $17.95K |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$7.87K |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$9.29K |
| Net Income | Q3 2025 · Dec 31, 2023 | −$1.42K |
| Net Income | Q3 2025 · Sep 30, 2023 | $0 |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | −$2K |
| Gross Profit restated | Q3 2025 · Mar 31, 2024 | $10.72K |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $2K |
| Cost Of Revenue restated | Q3 2025 · Mar 31, 2024 | $6.88K |
| Revenue | Q3 2025 · Mar 31, 2024 | $0 |
| Revenue | Q3 2025 · Mar 31, 2024 | $17.6K |